Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Caritis S
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Journal of Pharmaceutics and Drug Development
Related publications
12: Genetic Variation May Influence Response to 17-Alpha Hydroxyprogesterone Caproate (17P) for Recurrent Preterm Birth (PTB) Prevention
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
OC10.07: 17a-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth: Systematic Review and Meta-Analysis
Ultrasound in Obstetrics and Gynecology
Nuclear Medicine
Radiology
Ultrasound Technology
Gynecology
Reproductive Medicine
Radiological
Imaging
Obstetrics
Medicine
Quality Assessment of Compounded 17-Hydroxyprogesterone Caproate
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-Alpha-Hydroxyprogesterone Caproate
Journal of Obesity
Endocrinology
Metabolism
Diabetes
Response to Letter-To-The-Editor: Evaluation of 17-Alpha Hydroxyprogesterone Caproate Efficacy
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
379: Midtrimester Epigenetic Modifications of Nitric Oxide Pathway Genes in Maternal Circulating Blood and Placenta Among Women Exposed to 17-Alpha Hydroxyprogesterone Caproate (17P) for Recurrent Preterm Birth (PTB) Prevention
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Relationship Between 17-Hydroxyprogesterone Caproate Concentrations and Gestational Age at Delivery in Twin Gestation
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
591: Effect of Obesity on Efficacy of 17 Hydroxyprogesterone Caproate in Preventing Recurrent Preterm Birth
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Patient Characteristics Associated With 17-Alpha Hydroxyprogesterone Caproate Use Among a High-Risk Cohort
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
